Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer

被引：0
|
作者：
Maiko Asakuma
Michiko Yamamoto
Mayuko Wada
Shinichiro Ryuge
Ken Katono
Masanori Yokoba
Tomoya Fukui
Akira Takakura
Sakiko Otani
Sachiyo Maki
Satoshi Igawa
Tomoko Yanaihara
Hisashi Mitsufuji
Masaru Kubota
Masato Katagiri
Jiichiro Sasaki
Noriyuki Masuda
机构：
[1] Kitasato University School of Medicine,Department of Respiratory Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
CPT-11; Amrubicin; Small-cell lung cancer; Extensive stage; Phase 1 study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1529 / 1536
页数：7
相关论文
共 50 条
  • [1] Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer
    Asakuma, Maiko
    Yamamoto, Michiko
    Wada, Mayuko
    Ryuge, Shinichiro
    Katono, Ken
    Yokoba, Masanori
    Fukui, Tomoya
    Takakura, Akira
    Otani, Sakiko
    Maki, Sachiyo
    Igawa, Satoshi
    Yanaihara, Tomoko
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Masuda, Noriyuki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1529 - 1536
  • [2] CODE CHEMOTHERAPY WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    MASUDA, N
    FUKUOKA, M
    FURUSE, K
    NAGATA
    BUNN, PA
    GRECO, FA
    [J]. ONCOLOGY, 1992, 49 : 19 - 24
  • [3] Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer
    Tsukazaki, Yuki
    Ogino, Hirokazu
    Okano, Yoshio
    Kakiuchi, Soji
    Harada, Shoko
    Toyoda, Yuko
    Matsumura, Yugo
    Ichihara, Seiya
    Imakura, Takeshi
    Matsumoto, Rikako
    Ozaki, Ryohiko
    Ogawa, Ei
    Morita, Yutaka
    Mitsuhashi, Atsushi
    Yabuki, Yohei
    Yoneda, Hiroto
    Hanibuchi, Masaki
    Hase, Kayoko
    Takeuchi, Eiji
    Haku, Takashi
    Nishioka, Yasuhiko
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [4] Phase II trial of irinotecan plus cisplatin (IP) and etoposide plus cisplatin (EP) given weekly on alternating weeks with granulocyte colony-stimulating factor support in the treatment of extensive-stage small cell lung cancer
    Uyeki, J.
    Johnson, F. M.
    Feng, L.
    Peeples, B. O.
    Blumenschein, G. J.
    Fossella, F. V.
    Karp, D. D.
    Pisters, K. M.
    Stewart, D. J.
    Glisson, B. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and leukemia group B trial 9732
    Niell, HB
    Herndon, JE
    Miller, AA
    Watson, DM
    Sandler, AB
    Kelly, K
    Marks, RS
    Perry, MC
    Ansari, RH
    Otterson, G
    Ellerton, J
    Vokes, EE
    Green, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3752 - 3759
  • [6] Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: A phase II trial of the southwest oncology group
    Kelly, K
    Lovato, L
    Bunn, PA
    Livingston, RB
    Zangmeister, J
    Taylor, SA
    Roychowdhury, D
    Crowley, JJ
    Gandara, DR
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (08) : 2325 - 2329
  • [7] CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
    M Fukuoka
    N Masuda
    S Negoro
    K Matsui
    T Yana
    S Kudoh
    Y Kusunoki
    M Takada
    M Kawahara
    M Ogawara
    N Kodama
    K Kubota
    K Furuse
    [J]. British Journal of Cancer, 1997, 75 : 306 - 309
  • [8] CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
    Fukuoka, M
    Masuda, N
    Negoro, S
    Matsui, K
    Yana, T
    Kudoh, S
    Kusunoki, Y
    Takada, M
    Kawahara, M
    Ogawara, N
    Kodama, N
    Kubota, K
    Furuse, K
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (02) : 306 - 309
  • [9] Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
    Spigel, David R.
    Greco, F. Anthony
    Zubkus, John D.
    Murphy, Patrick B.
    Saez, Ruben A.
    Farley, Cindy
    Yardley, Denise A.
    Burris, Howard A., III
    Hainsworth, John D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1555 - 1560
  • [10] Phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive-stage small-cell lung cancer (WJTOG 0301)
    Iwamoto, Y.
    Kobayashi, M.
    Matsui, K.
    Yamamoto, H.
    Yamazaki, K.
    Saka, H.
    Sawa, T.
    Shibata, K.
    Takeda, K.
    Nakagawa, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345